首页> 美国卫生研究院文献>Anesthesiology Research and Practice >The Influence of Differences in Solvents and Concentration on the Efficacy of Propofol at Induction of Anesthesia
【2h】

The Influence of Differences in Solvents and Concentration on the Efficacy of Propofol at Induction of Anesthesia

机译:溶剂和浓度的差异对异丙酚诱导麻醉效果的影响

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Background. Propofol is a popular intravenous anesthetic and varieties of formulations were produced from different laboratories. The present study compared efficacy of propofol of different laboratories and different concentrations (1 and 2%) during induction of anesthesia. Methods. Seventy-five scheduled surgical patients were randomly allocated into three groups. The patients of group D1 received AstraZeneca Diprivan 1% (Osaka, Japan) at a rate of 40 mg kg−1 h−1. Group M1 was given 1% Maruishi (Maruishi Pharmaceutical, Osaka, Japan) and group M2 was given 2% formulation at the same rate of propofol. Achieving hypnosis was defined as failure to open their eyes in response to a verbal command and the venous blood sample was withdrawn. Results. The hypnotic doses of M2 were significantly larger (D1: 91.4 ± 30.9, M1: 90.7 ± 26.7, and M2: 118.4 ± 40.2 mg, resp. (mean ± SD). p < 0.005). Age and gender were selected as statistically significant covariates using general linear model-ANOVA. The blood concentration showed no significant difference among the groups (3.73 ± 2.34, 4.10 ± 3.04, and 4.70 ± 2.12 μg mL−1, resp.). Conclusion. The required dose of propofol was different among the formulations; however, the serum concentration showed no significant difference. This trial is registered with UMIN Clinical Trial Registry: .
机译:背景。丙泊酚是一种流行的静脉麻醉剂,各种制剂来自不同的实验室。本研究比较了在麻醉诱导期间不同实验室和不同浓度(1%和2%)的异丙酚的疗效。方法。预定的75名外科手术患者被随机分为三组。 D1组的患者接受40%mg kg -1 h -1 的阿斯利康Diprivan 1%(日本大阪)。给M1组服用1%丸石(日本大阪的丸石药业),给M2组服用2%的异丙酚制剂。实现催眠被定义为无法响应口头命令睁开眼睛,并抽取静脉血样本。结果。 M2的催眠剂量明显更大(D1:91.4±30.9,M1:90.7±26.7和M2:118.4±40.2μmg,分别为(均值±SD)。p <0.005)。使用一般线性模型ANOVA选择年龄和性别作为具有统计学意义的协变量。各组之间的血药浓度无显着差异(分别为3.73±2.34、4.10±3.04和4.70±2.12μgmL -1 )。结论。制剂中丙泊酚的所需剂量不同。但是,血清浓度无明显差异。该试验已在UMIN临床试验注册中心注册。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号